Skip to content

Influence of Oxytocin on Resting State Neurophysiological Measures

Influence of Oxytocin on Resting State Neurophysiological Measures

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03255148
Enrollment
56
Registered
2017-08-21
Start date
2017-07-24
Completion date
2018-05-18
Last updated
2019-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxytocin

Keywords

resting state, EEG, skin conductance, heart rate, oxytocin

Brief summary

In this study, the investigators will explore the influence of oxytocin administration on several neurophysiological responses (EEG, skin conductance and heart rate) during rest.

Detailed description

Oxytocin is known to influence several neurophysiological measures, such as heart rate, EEG and skin conductance during specific tasks (e.g., emotion recognition, fear learning and extinction). However, not much is known about the influence of oxytocin on those measures during rest. Therefore, in this randomized, placebo controlled, double blinded study, the investigators will investigate the influence of oxytocin during a resting period of 5 minutes. Heart rate, skin conductance, respiration and EEG will be measured before and after oxytocin or placebo administration. The investigators expect that oxytocin will increase the heart rate variability and decrease the skin conductance levels. Exploratory, the investigators will conduct a cross-frequency analysis of band power and asses the relationship between distinct indexes of sympathetic / parasympathetic balance. Please note that this study is part of a larger study in which the investigators also asses the influence of oxytocin on neurophysiological responses elicited by direct gaze

Interventions

DRUGOxytocin

Syntocinon nasal spray

DRUGPlacebo

Placebo nasal spray

Sponsors

Research Foundation Flanders
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* right-handed * male * age between 18 and 35 * Normal or adjusted-to-normal vision (with lenses only) * Dutch as mother tongue

Exclusion criteria

* not right-handed * female * age below 18 or above 35 * Need to wear glasses * Dutch not as mother tongue

Design outcomes

Primary

MeasureTime frameDescription
Change in heart rate variability after oxytocin administrationAssessment over 5 minutes, before and after oxytocin or placebo administrationThe influence of oxytocin administration on heart rate variability

Secondary

MeasureTime frameDescription
Change in skin conductance level after oxytocin administrationAssessment over 5 minutes, before and after oxytocin or placebo administrationThe influence of oxytocin administration on skin conductance level

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026